Related references
Note: Only part of the references are listed.Irisin: A Hope in Understanding and Managing Obesity and Metabolic Syndrome
Lidia L. Arhire et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Factors associated with circulating concentrations of irisin in the general population cohort of the ABCD study
S. Buscemi et al.
INTERNATIONAL JOURNAL OF OBESITY (2018)
Plasma Irisin Levels in Subjects with Type 1 Diabetes: Comparison with Healthy Controls
Anastasios Tentolouris et al.
HORMONE AND METABOLIC RESEARCH (2018)
Irisin a Novel Metabolic Biomarker: Present Knowledge and Future Directions
Ilse Yessabel Martinez Munoz et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2018)
Irisin in metabolic diseases
Stergios A. Polyzos et al.
ENDOCRINE (2018)
Physiology and role of irisin in glucose homeostasis
Nikolaos Perakakis et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Lower circulating irisin is associated with nonalcoholic fatty liver disease and type 2 diabetes
Mehrnoosh Shanaki et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2017)
The association of visceral adipose tissue and subcutaneous adipose tissue with metabolic risk factors in a large population of Chinese adults
Lizhi Tang et al.
CLINICAL ENDOCRINOLOGY (2016)
Lower Circulating Irisin Level in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis
X. -l. Du et al.
HORMONE AND METABOLIC RESEARCH (2016)
Circulating Serum Irisin Levels in Obesity and Type 2 Diabetes Mellitus
Amira Shoukry et al.
IUBMB LIFE (2016)
Association between circulating irisin and insulin resistance in non-diabetic adults: A meta-analysis
Shanhu Qiu et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Elevated circulating irisin is associated with lower risk of insulin resistance: association and path analyses of obese Chinese adults
Xiulin Shi et al.
BMC ENDOCRINE DISORDERS (2016)
Circulating Irisin Concentrations Are Associated with a Favourable Lipid Profile in the General Population
Simon Oelmann et al.
PLOS ONE (2016)
Irisin and Its Relation to Insulin Resistance and Puberty in Obese Children: A Longitudinal Analysis
Thomas Reinehr et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Circulating Irisin Levels Are Positively Associated with Metabolic Risk Factors in Sedentary Subjects
Mara Moreno et al.
PLOS ONE (2015)
High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects
G. Sesti et al.
ACTA DIABETOLOGICA (2014)
Irisin as a predictor of glucose metabolism in children: sexually dimorphic effects
Nasser M. Al-Daghri et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2014)
Association of Serum Irisin with Metabolic Syndrome in Obese Chinese Adults
Bing Yan et al.
PLOS ONE (2014)
Circulating Irisin in Relation to Insulin Resistance and the Metabolic Syndrome
Kyung Hee Park et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin Resistance
Jose Mara Moreno-Navarrete et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Lower circulating irisin is associated with type 2 diabetes mellitus
Jian-Jun Liu et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2013)
Decrease in Irisin in Patients with Chronic Kidney Disease
Ming-Shien Wen et al.
PLOS ONE (2013)
Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity - Correlation with body mass index
Andreas Stengel et al.
PEPTIDES (2013)
Irisin and FNDC5 in retrospect An exercise hormone or a transmembrane receptor?
Harold P. Erickson
ADIPOCYTE (2013)
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Pontus Bostroem et al.
NATURE (2012)
Muscles, exercise and obesity: skeletal muscle as a secretory organ
Bente K. Pedersen et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise
Joo Young Huh et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Cold-Activated Brown Adipose Tissue in Healthy Men
Wouter D. van Marken Lichtenbelt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
PGC-1α:: a key regulator of energy metabolism
Huiyun Liang et al.
ADVANCES IN PHYSIOLOGY EDUCATION (2006)
PGC-1α:: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes
S. Soyal et al.
DIABETOLOGIA (2006)
Inflammation and insulin resistance
Steven E. Shoelson et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies
C Barba et al.
LANCET (2004)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
AH Mokdad et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Share Paper
